Home/Filings/4/0001209191-14-066394
4//SEC Filing

Anacor Pharmaceuticals, Inc. 4

Accession 0001209191-14-066394

CIK 0001411158operating

Filed

Nov 3, 7:00 PM ET

Accepted

Nov 4, 7:06 PM ET

Size

5.4 KB

Accession

0001209191-14-066394

Insider Transaction Report

Form 4
Period: 2014-11-03
Plattner Jacob j
Senior VP Research
Transactions
  • Sale

    Common Stock

    2014-11-03$29.32/sh6,875$201,56372,100 total(indirect: See Footnote)
Footnotes (3)
  • [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2014.
  • [F2]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $29.18 to $29.80, inclusive.
  • [F3]These shares are held by Jacob & Jeanne Plattner Trust U/A 7/17/04, Jacob Plattner & Jeanne Plattner, Trustees.

Issuer

Anacor Pharmaceuticals, Inc.

CIK 0001411158

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001411158

Filing Metadata

Form type
4
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 7:06 PM ET
Size
5.4 KB